NV-LENOVO
Today at CES® 2023, Lenovo™ unveiled the latest lineup of devices and solutions focused on innovation and improving the user experience. From new form factors, beautiful design-led products, and innovative uses of AI, the new portfolio gives consumers and business users a more personalized technology experience.
The new portfolio also demonstrates Lenovo’s commitment to ESG in line with its vision of achieving net-zero by 2050 aligned to Science Based Target initiatives, Lenovo continues to focus on supporting a circular economy by increasing the use of recycled materials in its products and packaging, and collaborating with industry partners to help increase energy efficiency of its devices
Premium Consumer Devices Spotlight Innovation in Unexpected Ways
Lenovo introduced bold new products to address the wide-ranging needs of the modern consumer. The new, cutting-edge Yoga Book 9i hails a new chapter for Yoga with incredible innovation, premium style, and performance for versatile experiences. Redefining what an all-in-one desktop computer could look like, with the design-led Yoga AIO 9i. The new Yoga Slim 6i (14”, 8), known as Lenovo Slim 7 (14”, 8) in the U.S., is an exquisitely designed, portable, yet powerful device. Thin, lightweight, and attractive, this laptop empowers users to work and create content easily, whether on the move or at home.
Lenovo also introduced refreshes of its Yoga 9i (14”, 8) and Yoga Slim 7i Carbon (13”, 8), both featuring up to 13th Gen Intel Core processors, delivering an even more impressive performance to enhance versatility and productivity. Also, the refreshed Yoga 6 (13”, 8) laptop is power-forward and refreshed with the latest AMD Ryzen™ 7000 series processors and enhanced battery to handle longer remote work sessions.
In tablets, the feature-rich Lenovo Tab Extreme and Lenovo Smart Paper digital notepad deliver exciting capabilities for school, home, and beyond. The Lenovo Tab Extreme is Lenovo’s biggest and most powerful tablet yet, featuring a dual-hinge keyboard design2; unique, protective storage compartment is created within the main hinge of the stand for the included Lenovo Precision Pen 3.
Lenovo’s Project Chronos concept (formal name forthcoming) is a new technology that captures a user’s movement. It enables them to interact with and perform activities in 3D virtual worlds without glasses or wearables, making it easier than ever before for users to enter 3D-rendered virtual environments.
Innovative Technology for SMBs With a Twist
Lenovo announced an innovative new model in the ThinkBook Plus series that reimagines its strong heritage of the twistable form factor, with a dual rotating display that features an OLED panel on one side and a colorful e-Ink screen on the other. Lenovo also unveiled its latest ThinkBook 16p Gen 4 laptop powered by high performance components. This device features an innovative Lenovo Magic Bay modular accessory design with magnetic pin connector allowing easy expansion for optionally included Lenovo Magic Bay 4K Webcam, Lenovo Magic Bay LTE or Lenovo Magic Bay Light accessories.
Also, Lenovo introduced a new ThinkBook 13x Gen 2 Wireless Dock combining several wireless technologies to create a virtually cable-free docking and charging solution. Finally, Lenovo unveiled the latest in the portfolio of Tiny form factors. ThinkCentre neo 50q is a 1L space-saving desktop designed specifically for SMB customers.
Stylish and Smarter Ecosystem of Gaming Products
The 2023 Lenovo Legion lineup of battle-ready PCs, monitors, and accessories set a new standard in PC gaming that give gamers the edge they need to top leaderboards. New for 2023 is the Lenovo LA AI chip, the world’s first dedicated AI chip on a gaming laptop3, installed on the Lenovo Legion Pro 7 and 7i (16”, 8) laptops and the Lenovo Legion Pro 5 and 5i (16”, 8) laptops. Lenovo AI Engine+, powered by the Lenovo LA AI chip, deploys a software machine learning algorithm to optimally tune system performance.
On the desktop front, the new generation of Lenovo Legion towers stand at the pinnacle of extreme power and performance, with the Lenovo Legion Tower 7i (34L, 8) and Lenovo Legion Tower 5i (26L, 8) featuring up to 13th Gen Intel® Core™ desktop processors and NVIDIA® GeForce RTX™ 40 Series GPUs, while the Lenovo Legion Tower 5 (26L, 8) features up to AMD® Ryzen™ 9 processor and AMD Radeon™ RX 7000 series or NVIDIA GeForce RTX 40 Series GPUs. To round out the portfolio, Lenovo Legion’s newest monitors include the new 27-inch Lenovo Legion Y27f-30 FHD and 27-inch Lenovo Legion Y27qf-30 QHD displays that are engineered to meet the demands of gamers and content creators alike.
ThinkPad X1, ThinkPhone, ThinkVision and Lenovo Go Power Hybrid Working
Lenovo revealed its latest ThinkPad X1 laptops featuring recycled materials1, updated Lenovo Commercial Vantage software designed to highlight settings that can improve energy efficiency, and a new Lenovo View application, offering advanced computer vision technology for enhanced video image quality and tools for collaboration, security, and digital wellness. The latest line of ThinkVision monitors leads with the ultra-bright ThinkVision P27pz-30 and P32pz-30 mini-LED displays followed by ThinkVision’s new T-series VOIP monitors built for hybrid work, featuring an integrated Microsoft Teams functionality, 5MP cameras, dual microphones, and speakers. Lenovo also introduced its latest professional-grade 4K ThinkVision P-series monitors and, for the home, new value-conscious Lenovo L-series monitors. Completing an efficient hybrid eco-system are new accessories, including the unique Lenovo Go Desk Station, Lenovo Go 4K Pro Webcam, and Lenovo Professional Wireless Rechargeable Combo Keyboard and Mouse.
In celebrating the recent 30th anniversary of ThinkPad, meet the Lenovo ThinkPhone by Motorola, which is engineered to bring businesses a smartphone experience with the same trusted quality and reliability present on every Lenovo Think-branded device. This device arrives with a set of productivity experiences – Think 2 Think - that allows business end-users to enjoy seamless device integration between ThinkPhone and a ThinkPad. To ensure the device operates at peak performance for years to come, it is packed with the Snapdragon 8+ Gen 1 mobile platform, larger 6.6” FHD+ display and a 68W TurboPower universal charge that is able to charge both the phone and the PC.
Consumer Devices Delivering Next-Gen Features for Performance, Versatility, and Convenience
Lenovo’s latest generation of consumer devices are loaded with standout features and enhancements designed to help people connect with their passions and achieve their daily goals. With five new performance-driving and portable IdeaPad laptops (IdeaPad Pro 5i, IdeaPad Pro 5 Gen 8, IdeaPad Slim 5i, IdeaPad Slim 5 and IdeaPad Flex 3i Chromebook), the sleek and compact IdeaCentre Mini (1L, 8) desktop, a 9-inch Lenovo tablet (Lenovo Tab M9), and the versatile Lenovo 500 USB Type-C Universal Dock, these devices are designed for all the spaces and places in line with the on-the-go lifestyle of today’s consumer. Whether working, studying, creating, or just catching up with friends out of town, these new products offer speed, versatility, and convenience to suit their needs wherever they are.
Supporting Services and Software
In addition to these premium hardware options, Lenovo offers a range of device health, support, and protection services to help keep products running at peak condition and more secure, like its latest cloud-based security software Lenovo Smart Lock4. For an added level of convenience in supporting the laptops introduced today, Lenovo Premium Care Plus5 incorporates many of its services into one solution. This comprehensive service includes advanced hardware and software support, Accidental Damage Protection, an extended battery warranty, Lenovo Migration Assistant, and Lenovo Smart Performance – a self-diagnostic system health check found within Lenovo Vantage.
Lenovo continues 30th anniversary of the ThinkPad at CES 2023
Lenovo is continuing celebrations of ThinkPad's 30th anniversary and bringing a virtual Think On Theater to CES and beyond. The Think On Theater will feature content from our Next 30, including Alice Aedy, Marcus John and Bjarke Ingels. To check out the virtual Think On Theater, visit Lenovo's Virtual Showcase starting January 5.
More info on all of Lenovo’s new product announcements can be found in the CES 2023 press kit on Lenovo StoryHub:
- Lenovo Goes Bigger and Bolder with New Dual-Screen Yoga Book 9i and Premium Consumer Devices that Spotlight Innovation in Unexpected Ways
- ThinkBook Plus Reinvents Rotating Display Form Factor with New Twist Laptop
- ThinkPad X1, ThinkVision and Lenovo Go Power Hybrid Working
- Stylish, Savage, and Smarter: Lenovo unveils the world’s most powerful 16-inch AI-tuned gaming laptops and an ecosystem of gaming products that fuse epic experiences and sophisticated aesthetics
- Lenovo’s New Consumer Devices Deliver Next-Gen Features for Performance, Versatility, and Convenience
- Meet the new Lenovo ThinkPhone by Motorola for unmatched business device experience
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 82,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into key growth areas including server, storage, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere. To find out more, visit https://www.lenovo.com and read about the latest news on Lenovo StoryHub.
1 Previous generation ThinkPad X1 Carbon, X1 Yoga and X1 Nano did not use recycled metals |
2 Dual-hinge keyboard stand is sold separately in some markets |
3 Based on internal research conducted as of October 24, 2022, comparing 16” gaming laptops distributed by global PC manufacturers shipping > 1 million units worldwide annually, and supported by the combination of a dedicated AI chip or AI engine and NVIDIA GeForce RTX TGP (140W+) graphics. |
4 Lenovo Smart Lock is available through Lenovo Vantage and only applicable on Lenovo PCs with Windows 10 or 11. |
5 Premium Care Plus products are applicable to the desktops, laptops and tablets in this announcement, and are subject to availability. The service is available in select markets and service level may vary by geographic location. Lenovo reserves the right to alter product offerings and specifications at any time, without notice. |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005201/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom